top of page

myLaminin Perspectives


ICH E6 (R3) Is Here: What It Actually Means for Clinical Trials and Why It Matters Now
ICH E6 (R3) is reshaping clinical trial compliance across Canada, the U.S., EU, UK, and Australia. The updated Good Clinical Practice (GCP) guideline emphasizes Quality by Design, proactive risk management, audit trail traceability, sponsor oversight, informed consent, data integrity, and inspection readiness. myLaminin helps research teams and sponsors manage multi-site clinical trials with real-time oversight, CTQ monitoring, compliant eConsent, secure audit trails, and val

Deanne Bassili
May 74 min read


Maximizing the Clinical Impact of Digital Twins Through Integrated Research Data Management
Digital twins are transforming personalized healthcare, but their impact depends on secure, interoperable data. myLaminin enables this with an integrated Research Data Management platform that unifies eConsent, CTMS, HL7 FHIR integration, and secure repositories. The result: compliant, AI-driven digital twin models that continuously learn, improve, and deliver more accurate clinical outcomes.

Ash Bassili
Apr 74 min read
bottom of page